Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.05 - $24.02 $552,330 - $735,012
30,600 Added 64.15%
78,300 $1.45 Million
Q2 2024

Aug 14, 2024

BUY
$18.65 - $28.5 $736,675 - $1.13 Million
39,500 Added 481.71%
47,700 $922,000
Q1 2024

May 15, 2024

BUY
$24.74 - $35.13 $32,161 - $45,669
1,300 Added 18.84%
8,200 $221,000
Q4 2023

Feb 14, 2024

SELL
$21.62 - $37.21 $108,100 - $186,050
-5,000 Reduced 42.02%
6,900 $247,000
Q3 2023

Nov 14, 2023

BUY
$27.34 - $55.37 $221,454 - $448,497
8,100 Added 213.16%
11,900 $336,000
Q2 2023

Aug 14, 2023

BUY
$26.1 - $49.92 $10,440 - $19,968
400 Added 11.76%
3,800 $189,000
Q4 2022

Feb 14, 2023

SELL
$16.24 - $26.38 $110,431 - $179,384
-6,800 Reduced 66.67%
3,400 $63,000
Q3 2022

Nov 14, 2022

BUY
$23.95 - $34.71 $244,290 - $354,042
10,200 New
10,200 $255,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.33B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.